Zhitong Finance App News, Keyuan Pharmaceutical (301281.SZ) announced that Shandong Linuo Pharmaceutical Co., Ltd. (“Linuo Pharmaceutical”), a wholly-owned subsidiary of the company, recently received a drug registration certificate issued by the State Drug Administration. Drug names: englizine metformin sustained-release tablets (III), engagliptin metformin sustained-release tablets (IV).

Engagliflozin metformin extended-release tablets are used in combination with diet control and exercise for adult patients with type 2 diabetes who are receiving engagliptin and metformin hydrochloride to improve blood sugar control in these patients.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.